SlideShare a Scribd company logo
1 of 65
GLYCOGEN METABOLISM
GLYCOGEN METABOLISM
Carl Cori and Gerty -glycogen degradation.
 Glycogen synthesis, Luis Leloir (Argentina) was
awarded Nobel prize in 1970.
Earl Sutherland studied the role of cyclic AMP as
the second messenger in glycogenolysis.
Glycogen is a homopolysaccharide with glucose
units linked in alpha-1, 4 linkages (straight line) and
alpha-1, 6 linkages (branching point).
Branching makes the molecule more globular and
less space-consuming.
FIG. Pathways of glycogenesis and glycogenolysis in the liver.
FIG. Control of glycogen phosphorylase in muscle. The sequence of reactions arranged as a
cascade allows amplification of the hormonal signal at each step. n, number of glucose residue
Fig . Coordinated control of glycogenolysis and
glycogenesis by cAMP dependent protein kinase.
 Coordinated control of glycogenolysis and glycogenesis by
cAMP-dependent protein kinase.
 The reactions that lead to glycogenolysis as a result of an
increase in cAMP concentrations are shown with bold
arrows.
 Inhibited by activation of protein phosphatase-1 are shown
with dashed arrows.
 The reverse occurs when cAMP concentrations decrease as
a result of phosphodiesterase activity, leading to
glycogenesis.
Functions of Glycogen
1. storage form , liver and
muscle.
liver glycogen is to provide glucose during fasting.
The glycogen content of liver (10 g/100 g tissue)
 skeletal muscle (1–2 g/100 g)
2. liver glycogen is broken down and helps to
maintain blood glucose level.
 After taking food, blood sugar tends to rise,
Functions of Glycogen continue…
 After taking food, blood sugar tends to rise, which
causes glycogen deposition in liver.
About 5 hours after taking food, the blood sugar tends
to fall.
But, glycogen is lyzed to glucose so that the energy
needs are met.
After about 18 hours fasting, most of the liver glycogen
is depleted, when depot fats are hydrolyzed and energy
requirement is met by fatty acid oxidation .
3. The function of muscle glycogen is to act as reserve
fuel for muscle contraction.
4. All the enzymes related to glycogen metabolism are
cytoplasmic.
DEGRADATION OF GLYCOGEN
(GLYCOGENOLYSIS)
-Steps of Glycogenolysis
Step 1 -Glycogen Phosphorylase
i. Glycogen phosphorylase removes glucose as glucose- 1-
phosphate from glycogen (phosphorolysis) .
It contains pyridoxal phosphate (PLP) as a prosthetic
group. The alpha-1, 4 linkages in the glycogen are cleaved.
ii. It removes glucose units one at a time. Enzyme
sequentially hydrolyzes alpha-1, 4 glycosidic linkages,
Step 2.Debranching by Bifunctional (Two) Enzymes
i. A block of 3 glucose residues (trisaccharide unit) are
transferred from the branching point to another branch.
 Enzyme is alpha-1, 4 → alpha-1, 4 glucan transferase.
ii. Now the branch point is free.
 Then alpha-1, 6- glucosidase (debranching enzyme) can
hydrolyze the remaining glucose unit held in alpha-1, 6
linkage at the branch point .
iii. This glucose residue is released as free glucose ,the ratio of
glucose-1-phosphate to free glucose is about 8:1.
iv. The transferase and alpha-1, 6-glucosidase will together
convert the branch point to a linear one.
 With the removal of the branch point, phosphorylase nzyme
can proceed with its action.
Sep 3. Phosphoglucomutase
Phosphorylase reaction produces glucose-1-
phosphatem while debranching enzyme releases
glucose.
The glucose- 1-phosphate is converted to glucose-6-
phosphate by phosphoglucomutase .
Step 4.Glucose-6-phosphatase in Liver
Next, hepatic glucose-6-phosphatase hydrolyzes
glucose- 6-phosphate to glucose.
The free glucose is released to the bloodstream.
Muscle lacks Glucose -6-phosphatase
Muscle will not release glucose to the
bloodstream, because muscle tissue does not
contain the glucose-6-phosphatase.
Instead, in muscle, glucose-6-phosphate
undergoes glycolysis to produce ATP for muscle
contraction.
Energetics Glycogenolysis
i. The energy yield from one glucose residue derived
from glycogen is 3 ATP molecules, because no ATP is
required for initial phosphorylation of glucose (step
1 of glycolysis).
ii. If glycolysis starts from free glucose only 2 ATPs are
produced.
GLYCOGEN SYNTHESIS
(GLYCOGENESIS)
GLYCOGEN SYNTHESIS (GLYCOGENESIS)
The glycogen synthesis occurs by a pathway
distinctly different from the reversal of glycogen
breakdown, which would prevent the operation of
futile cycles.
The steps are:
Step-1. Activation of Glucose
UDP glucose is formed from glucose-1-phosphate
and UTP (uridine triphosphate) by the enzyme UDP-
glucose pyrophosphorylase.
Step- 2.Glycogen Synthase
The glucose moiety from UDP-glucose is transferred
to a glycogen primer (glycogenin) molecule.
The primer is essential to accept the glycosyl unit.
The primer is made up of a protein-carbohydrate
complex.
It is a dimeric protein, having two identical
monomers.
An oligosaccharide chain of 7 glucose units is added
to each monomer.
Step- 2.Glycogen Synthase continue….
In the next step, activated glucose units are
sequentially added by the enzyme glycogen
synthase .
The glucose unit is added to the nonreducing
(outer) end of the glycogen primer to form an
alpha-1, 4 glycosidic linkage and UDP is liberated.
Glycogen Synthase and Primer
The glycogen primer is formed by autoglycosylation
of glycogenin.
Glycogenin is a dimeric protein, the monomers
glycosylating each other using UDP glucose till
seven glucose units are added.
 This molecule acts as the glycogen primer to which
glucose units are added by glycogen synthase.
Step-3.Branching Enzyme
i. The glycogen synthase can add glucose units only in
alpha-1, 4 linkage.
 A branching enzyme is needed to create the alpha-1,
6 linkages.
ii. When the chain is lengthened to 11–12 glucose
residues, the branching enzyme will transfer a block of
6 to 8 glucose residues from this chain to another site
on the growing molecule.
The enzyme amylo- [1, 4]→[1, 6]-transglucosidase
(branching enzyme) forms this alpha-1, 6 linkage.
iii. To this newly created branch, further glucose units can
be added in alpha-1, 4 linkage by glycogen synthase.
Regulation of Glycogen Metabolism
i. The synthesis and degradation pathways are reciprocally regulated
to prevent futile cycles.
ii. The phosphorylated form of glycogen phosphorylase is active;
but glycogen synthase becomes inactive on phosphorylation.
 The covalently modified phosphorylase is active even without
AMP.
 Active (dephosphorylated) glycogen synthase is responsive to the
action of glucose-6- phosphate.
 Covalent modification modulates the effect of allosteric regulators.
 The hormonal control by covalent modification and allosteric
regulation are
interrelated.
iii. These hormones act through a second messenger, cyclic AMP
(cAMP)
iv. The covalent modification of glycogen phosphorylase
and synthase is by a cyclic AMP mediated
Regulation of Glycogen Metabolism
iv. The covalent modification of glycogen
phosphorylase and synthase is by a cyclic AMP
mediated cascade.
 Specific protein kinases bring about
phosphorylation and protein phosphatases cause
dephosphorylation.
Regulation of Glycogen Metabolism
Generation of Cyclic AMP (cAMP)
Protein Kinase Activation
Phosphorylase Kinase Activation
Glycogen Phosphorylase in Liver and Muscle
Glycogen Synthase
Generation of Cyclic AMP (cAMP)
i. Both liver and muscle phosphorylases are activated by
a cyclic AMP mediated activation cascade triggered
by the hormonal signal.
ii. The hormones epinephrine and glucagon can
activate liver glycogen phosphorylase but glucagon
has no effect on the muscle.
iii. When the hormone binds to a specific receptor on
the plasma membrane, the enzyme adenyl cyclase is
activated which converts ATP to cyclic AMP (cAMP).
iv. When level of cyclic AMP rises, it will activate a
protein kinase .
Protein Kinase Activation
The protein kinase is inactive when the catalytic (C)
and regulatory (R) subunits are associated with
each other.
Earl Sutherland studied the role of cyclic AMP as the
second messenger in glycogenolysis.
The cAMP combines with the R subunit so that the
C subunit is free to have its catalytic activity.
 PKA is an enzyme that can phosphorylate serine
and threonine residues of several enzyme proteins
and is activated by cAMP which combines with the
regulatory subunit of PKA.
In the absence of cAMP, PKA is an inactive tetramer.
Protein Kinase Activation
Protein Kinase Activation
The intracellular concentration of cAMP therefore
decides the level of active PKA.
 cAMP level depends on the activity of adenylate
cyclase and phosphodiesterase.
Cyclic AMP level is increased by glucagon and
decreased by insulin.
Phosphorylase Kinase Activation
 The active protein kinase can now convert the phosphorylase
 kinase to an active phosphorylated form, which converts
 phosphorylase-b to phosphorylase-a .
 Phosphorylase kinase itself is a tetrameric enzyme (alpha,
beta, gamma, delta).
 The gamma subunit has the catalytic site and the other 3
subunits have regulatory effects.
 Phosphorylase kinase is activated by Ca++ and
phosphorylation of alpha and beta subunits by PKA.
 Phosphorylation of alpha and beta subunits relieves
autoinhibition of catalytic activity of gamma subunit.
 Binding of Ca++ to the delta subunit which is identical to
calmodulin (CaM) is also necessary for full activity of delta
subunit. since it also has a role in dysregulating the
Phosphorylase Kinase Activation continue..
 It also has a role in dysregulating the gamma
subunit.
 Calcium triggers muscle contraction as well as
glycogen breakdown through the action of
phosphorylase kinase.
 The rate of glycogenolysis is linked to rate of
muscle contraction.
Phosphorylase Kinase Activation continue..
 The dephosphorylation of the active form by protein
phosphatase 1 (PP1) involves removal of phosphate group
from phosphorylase a and alpha and beta subunits of
phosphorylase kinase.
 The activity of PP1 is controlled differently in liver and
muscle.
 The catalytic subunit of PP1 in muscle is active only when it is
bound to glycogen through the glycogen binding GM subunit.
 The phosphorylation of PP1 by an insulin stimulated protein
kinase (site1) activates the enzyme where as phosphorylation
at site 2 by PKA makes its action ineffective.
 When cAMP level is high, PP1 is inhibited by inhibitor1 which
is activated by phosphorylation by PKA.
 The effect of cyclic AMP is not only by increasing the
phosphorylation of enzymes, but also by decreasing
dephosphorylation.
Glycogen Phosphorylase in Liver
a. Liver: The liver phosphorylase-b is the inactive form.
 It becomes active on phosphorylation.
 The active enzyme is denoted as phosphorylase-a.
 The enzyme is inhibited by ATP and glucose-6-phosphate.
 In the liver the PP1 is regulated differently through the
intermediary of glycogen binding subunit (GL).
 GL complex can bind to R and T forms of phosphorylase a.
 The phosphate group attached to ser14 is exposed only in
the T state, so that PP1 can convert phosphorylase a to
phosphorylase b.
 Glucose is an allosteric inhibitor of phosphorylase a.
 Insulin favors this effect by promoting the uptake and
phosphorylation of glucose.
Glycogen Phosphorylase in Muscle
b. Muscle: Skeletal muscle glycogen is degraded only when the
demand for ATP is high.
 The regulation of glycogenolysis in skeletal muscle is by
epinephrine.
 Glucagon has no effect on muscle glycogenolysis.
 AMP formed by degradation of ATP during muscle contraction
is an allosteric activator of phosphorylase b.
 The active form of phosphorylase is referred to as ‘a’ (active,
phosphorylated) and the relatively inactive dephosphorylated
form as ‘b’.
 The active glycogen synthase (a) is dephosphorylated and
phosphorylated (b) is relatively inactive.
 Glycogen phosphorylase is activated by phosphorylation by
phosphorylase kinase that adds phosphate group to a specific
serine residue of phosphorylase b (ser14).
 This phosphorylase kinase, in
FIG. Control of glycogen phosphorylase in muscle. The sequence of reactions arranged as a
cascade allows amplification of the hormonal signal at each step. n, number of glucose residue
Glycogen Phosphorylase in Muscle
 This phosphorylase kinase, in turn, is activated by
protein kinase A or cyclic AMP dependent protein
kinase.
 Phosphoprotein phosphatase I dephosphorylates
both phosphorylase kinase and phosphorylase b.
Phosphorylase b is sensitive to allosteric effectors
like AMP but phosphorylase a is not sensitive.
High concentration of ATP and glucose-6-phosphate
in the cell will inhibit phosphorylase b.
Glycogen Synthase
i. Glycogen synthase and phosphorylase activities are
reciprocally regulated .
ii. The same protein kinase, which phosphorylates the
phosphorylase kinase would also phosphorylate glycogen
synthase.
iii. The activity of the glycogen synthase is markedly decreased
on phosphorylation.
 Insulin promotes glycogen synthesis by favouring
dephosphorylation.
 Glycogen synthase is active in the dephosphorylated state.
 Phosphorylase kinase can phosphorylate glycogen synthase
and inactivate the enzyme.
 PKA can also inactivate the enzyme by phosphorylation.
 Ca++ and calcium dependent cam kinase also phosphorylate
the enzyme.
Glycogen Synthase continue….
Relative rates of glycogen synthesis and breakdown are
controlled by the action of PKA, phosphorylase kinase
and PP1.
PP1 can activate glycogen synthase only after
dephosphorylating and inactivating phosphorylase a.
The regulation of glycogen phosphorylase and synthase
is a typical example of multisite phosphorylation
(primary and secondary sites) for metabolic regulation.
Control by allosteric effectors is superimposed on
covalent modification.
 Glucose-6-phosphate can activate glycogen synthesis.
Insulin activates PP1 and PDE which decreases cAMP
level and increases G6P level to promote glycogen
synthesis.
Glycogen Synthase continue….
The reciprocal regulation of glycogenolysis and
glycogenesis is by covalent modification
(phosphorylation and dephosphorylation).
 Insulin and glucagon are the major regulatory
hormones, although epinephrine has stimulatory
effect on glycogenolysis in both liver and muscle.
They bring about alterations in the activity of
protein kinases and phosphatases by varying the
level of cAMP.
Summary of Glycogen Regulation
i. The key enzyme for glycogenolysis is phosphorylase, which
is activated by glucagon and epinephrine, under the
stimulus of hypoglycemia.
ii. The key enzyme for glycogen synthesis is glycogen
synthase, the activity of which is decreased by glucagon
and epinephrine but is enhanced by insulin, under the
stimulus of hyperglycemia .
 Glycogen metabolism is regulated by coordinated
regulation of glycogen synthase and
glycogenphosphorylase.
 The regulatory mechanisms include:
 Allosteric control as well as hormonal control by covalent
modification of enzymes.
 The allosteric effectors are ATP, glucose-6-phosphate and
AMP.
GLYCOGEN STORAGE DISEASES
• These are inborn-errors of metabolism.
Glycogen Storage Disease Type-I
1. It is also called Von Gierke’s Disease.
 Most common type of glycogen storage disease is type I.
2. Incidence is 1 in 100,000 live births.
3. Glucose-6-phosphatase is deficient.
4. Fasting hypoglycemia that does not respond to stimulation by adrenaline.
 The glucose cannot be released from liver during over night fasting 5.
Hyperlipidemia, lactic acidosis and ketosis.
6. Glucose-6-phosphate is accumulated, so it is channeled to HMP shunt
pathway producing more ribose and more purine nucleotides.
7. Purines are then catabolized to uric acid, leading to hyperuricemia.
8. Glycogen gets deposited in liver.
 Massive liver enlargement may lead to cirrhosis.
9. Children usually die in early childhood.
10. Treatment is to give small quantity of food at frequent intervals.
 Other types : 1 in 1 million births
Pompe’s disease
• infantile-onset Pompe’s disease Myozyme
(recombinant human acid alpha glucosidase,
rhGAA) is administered intravenously.

More Related Content

What's hot

7 glycogen metabolism
7 glycogen metabolism7 glycogen metabolism
7 glycogen metabolism
dream10f
 

What's hot (20)

GLYCOGENOLYSIS & REGULATION OF GLYCOGEN METABOLISM
GLYCOGENOLYSIS & REGULATION OF GLYCOGEN METABOLISMGLYCOGENOLYSIS & REGULATION OF GLYCOGEN METABOLISM
GLYCOGENOLYSIS & REGULATION OF GLYCOGEN METABOLISM
 
glycogenesis and glycogenolysis
glycogenesis and glycogenolysis glycogenesis and glycogenolysis
glycogenesis and glycogenolysis
 
METABOLISM OF GALACTOSE, FRUCTOSE & AMINO SUGARS
METABOLISM OF GALACTOSE, FRUCTOSE & AMINO SUGARSMETABOLISM OF GALACTOSE, FRUCTOSE & AMINO SUGARS
METABOLISM OF GALACTOSE, FRUCTOSE & AMINO SUGARS
 
Metabolism of glycogen
Metabolism of glycogenMetabolism of glycogen
Metabolism of glycogen
 
Gluconeogenesis
GluconeogenesisGluconeogenesis
Gluconeogenesis
 
Glycogenolysis
GlycogenolysisGlycogenolysis
Glycogenolysis
 
Gluconeogenesis
GluconeogenesisGluconeogenesis
Gluconeogenesis
 
Fructose & galactose metabolism
Fructose & galactose metabolismFructose & galactose metabolism
Fructose & galactose metabolism
 
GLACTOSE METABOLISM
GLACTOSE METABOLISMGLACTOSE METABOLISM
GLACTOSE METABOLISM
 
Gluconeogenesis
GluconeogenesisGluconeogenesis
Gluconeogenesis
 
Glycogen Metabolism
Glycogen Metabolism Glycogen Metabolism
Glycogen Metabolism
 
biochemistry slides for mbbs on metabolism of mono saccherides
biochemistry slides for mbbs on metabolism of mono saccheridesbiochemistry slides for mbbs on metabolism of mono saccherides
biochemistry slides for mbbs on metabolism of mono saccherides
 
Glycogen Metabolism .
Glycogen Metabolism .Glycogen Metabolism .
Glycogen Metabolism .
 
URONIC ACID PATHWAY
URONIC ACID PATHWAYURONIC ACID PATHWAY
URONIC ACID PATHWAY
 
Glycogen metabolism
Glycogen metabolismGlycogen metabolism
Glycogen metabolism
 
Gluconeogenesis and glycogenolysis
Gluconeogenesis and glycogenolysisGluconeogenesis and glycogenolysis
Gluconeogenesis and glycogenolysis
 
7 glycogen metabolism
7 glycogen metabolism7 glycogen metabolism
7 glycogen metabolism
 
Gluconeogenesis
Gluconeogenesis Gluconeogenesis
Gluconeogenesis
 
Glycogen Metabolism
Glycogen MetabolismGlycogen Metabolism
Glycogen Metabolism
 
Glycogenesis and glycogenolysis
Glycogenesis and glycogenolysisGlycogenesis and glycogenolysis
Glycogenesis and glycogenolysis
 

Similar to Glycogen metabolism

Lec09 glycogen met
Lec09 glycogen metLec09 glycogen met
Lec09 glycogen met
dream10f
 
GLYCOGEN METABOLISM IN ANIMALS FOR VETS.pdf
GLYCOGEN METABOLISM IN ANIMALS FOR VETS.pdfGLYCOGEN METABOLISM IN ANIMALS FOR VETS.pdf
GLYCOGEN METABOLISM IN ANIMALS FOR VETS.pdf
TatendaMageja
 

Similar to Glycogen metabolism (20)

Lec09 glycogen met
Lec09 glycogen metLec09 glycogen met
Lec09 glycogen met
 
GLYCOGENOLYSIS.pptx
GLYCOGENOLYSIS.pptxGLYCOGENOLYSIS.pptx
GLYCOGENOLYSIS.pptx
 
GLYCOLYSIS & ITS REGULATION
GLYCOLYSIS & ITS REGULATIONGLYCOLYSIS & ITS REGULATION
GLYCOLYSIS & ITS REGULATION
 
Glycolysis
GlycolysisGlycolysis
Glycolysis
 
Glycogen metabolism s
Glycogen metabolism sGlycogen metabolism s
Glycogen metabolism s
 
Metabolism of glycogen and its clinical significance final.pptx
Metabolism of glycogen and its clinical significance final.pptxMetabolism of glycogen and its clinical significance final.pptx
Metabolism of glycogen and its clinical significance final.pptx
 
Glycogen regulation and its metabolism .pdf
Glycogen regulation and its metabolism .pdfGlycogen regulation and its metabolism .pdf
Glycogen regulation and its metabolism .pdf
 
Regulation of glycolysis and gluconeogenesis
Regulation of glycolysis and gluconeogenesisRegulation of glycolysis and gluconeogenesis
Regulation of glycolysis and gluconeogenesis
 
Glycogen metabolism
Glycogen metabolismGlycogen metabolism
Glycogen metabolism
 
Glycolysis
GlycolysisGlycolysis
Glycolysis
 
GLYCOGEN METABOLISM IN ANIMALS FOR VETS.pdf
GLYCOGEN METABOLISM IN ANIMALS FOR VETS.pdfGLYCOGEN METABOLISM IN ANIMALS FOR VETS.pdf
GLYCOGEN METABOLISM IN ANIMALS FOR VETS.pdf
 
Glycogenolysis
GlycogenolysisGlycogenolysis
Glycogenolysis
 
Carbohydrate metabolism
Carbohydrate metabolismCarbohydrate metabolism
Carbohydrate metabolism
 
Regulation of Glycolysis | Glycolysis and Regulation Mechanism
Regulation of Glycolysis | Glycolysis and Regulation MechanismRegulation of Glycolysis | Glycolysis and Regulation Mechanism
Regulation of Glycolysis | Glycolysis and Regulation Mechanism
 
Regulation of Glycolysis and TCA cycle
Regulation of Glycolysis and TCA cycleRegulation of Glycolysis and TCA cycle
Regulation of Glycolysis and TCA cycle
 
Glycolysis - Glucose oxidation
Glycolysis - Glucose oxidationGlycolysis - Glucose oxidation
Glycolysis - Glucose oxidation
 
glycogen metabolism
glycogen metabolismglycogen metabolism
glycogen metabolism
 
Glycogenolysis biochemistry.ppt[1]
Glycogenolysis biochemistry.ppt[1]Glycogenolysis biochemistry.ppt[1]
Glycogenolysis biochemistry.ppt[1]
 
Glycogen Metabolism and Control
Glycogen Metabolism and ControlGlycogen Metabolism and Control
Glycogen Metabolism and Control
 
CARBOHYDRATE METABOLISM : GLYCOLYSIS
CARBOHYDRATE METABOLISM : GLYCOLYSISCARBOHYDRATE METABOLISM : GLYCOLYSIS
CARBOHYDRATE METABOLISM : GLYCOLYSIS
 

More from Koppukonda Shanthi (9)

Mechanisms of action of hormones and signaling molecules
Mechanisms of action of hormones  and signaling moleculesMechanisms of action of hormones  and signaling molecules
Mechanisms of action of hormones and signaling molecules
 
Fat soluble vitamin :Vitamin A
Fat soluble vitamin :Vitamin AFat soluble vitamin :Vitamin A
Fat soluble vitamin :Vitamin A
 
Albumin
Albumin Albumin
Albumin
 
Thyroid hormone
Thyroid hormoneThyroid hormone
Thyroid hormone
 
Hormones
HormonesHormones
Hormones
 
Vitamin B2 (RIBOFLAVIN)
Vitamin B2 (RIBOFLAVIN)Vitamin B2 (RIBOFLAVIN)
Vitamin B2 (RIBOFLAVIN)
 
The citric acid cycle
The citric acid cycleThe citric acid cycle
The citric acid cycle
 
Water soluble vitamins -B1
Water soluble vitamins -B1Water soluble vitamins -B1
Water soluble vitamins -B1
 
Nucleotides chemistry and metabolism
Nucleotides chemistry and metabolismNucleotides chemistry and metabolism
Nucleotides chemistry and metabolism
 

Recently uploaded

Physiologic Anatomy of Heart_AntiCopy.pdf
Physiologic Anatomy of Heart_AntiCopy.pdfPhysiologic Anatomy of Heart_AntiCopy.pdf
Physiologic Anatomy of Heart_AntiCopy.pdf
MedicoseAcademics
 
Difference Between Skeletal Smooth and Cardiac Muscles
Difference Between Skeletal Smooth and Cardiac MusclesDifference Between Skeletal Smooth and Cardiac Muscles
Difference Between Skeletal Smooth and Cardiac Muscles
MedicoseAcademics
 
Obat Aborsi Ampuh Usia 1,2,3,4,5,6,7 Bulan 081901222272 Obat Penggugur Kandu...
Obat Aborsi Ampuh Usia 1,2,3,4,5,6,7 Bulan  081901222272 Obat Penggugur Kandu...Obat Aborsi Ampuh Usia 1,2,3,4,5,6,7 Bulan  081901222272 Obat Penggugur Kandu...
Obat Aborsi Ampuh Usia 1,2,3,4,5,6,7 Bulan 081901222272 Obat Penggugur Kandu...
Halo Docter
 

Recently uploaded (20)

Dr. A Sumathi - LINEARITY CONCEPT OF SIGNIFICANCE.pdf
Dr. A Sumathi - LINEARITY CONCEPT OF SIGNIFICANCE.pdfDr. A Sumathi - LINEARITY CONCEPT OF SIGNIFICANCE.pdf
Dr. A Sumathi - LINEARITY CONCEPT OF SIGNIFICANCE.pdf
 
Physiologic Anatomy of Heart_AntiCopy.pdf
Physiologic Anatomy of Heart_AntiCopy.pdfPhysiologic Anatomy of Heart_AntiCopy.pdf
Physiologic Anatomy of Heart_AntiCopy.pdf
 
HISTORY, CONCEPT AND ITS IMPORTANCE IN DRUG DEVELOPMENT.pptx
HISTORY, CONCEPT AND ITS IMPORTANCE IN DRUG DEVELOPMENT.pptxHISTORY, CONCEPT AND ITS IMPORTANCE IN DRUG DEVELOPMENT.pptx
HISTORY, CONCEPT AND ITS IMPORTANCE IN DRUG DEVELOPMENT.pptx
 
7 steps How to prevent Thalassemia : Dr Sharda Jain & Vandana Gupta
7 steps How to prevent Thalassemia : Dr Sharda Jain & Vandana Gupta7 steps How to prevent Thalassemia : Dr Sharda Jain & Vandana Gupta
7 steps How to prevent Thalassemia : Dr Sharda Jain & Vandana Gupta
 
VIP ℂall Girls Arekere Bangalore 6378878445 WhatsApp: Me All Time Serviℂe Ava...
VIP ℂall Girls Arekere Bangalore 6378878445 WhatsApp: Me All Time Serviℂe Ava...VIP ℂall Girls Arekere Bangalore 6378878445 WhatsApp: Me All Time Serviℂe Ava...
VIP ℂall Girls Arekere Bangalore 6378878445 WhatsApp: Me All Time Serviℂe Ava...
 
MOTION MANAGEMANT IN LUNG SBRT BY DR KANHU CHARAN PATRO
MOTION MANAGEMANT IN LUNG SBRT BY DR KANHU CHARAN PATROMOTION MANAGEMANT IN LUNG SBRT BY DR KANHU CHARAN PATRO
MOTION MANAGEMANT IN LUNG SBRT BY DR KANHU CHARAN PATRO
 
Face and Muscles of facial expression.pptx
Face and Muscles of facial expression.pptxFace and Muscles of facial expression.pptx
Face and Muscles of facial expression.pptx
 
See it and Catch it! Recognizing the Thought Traps that Negatively Impact How...
See it and Catch it! Recognizing the Thought Traps that Negatively Impact How...See it and Catch it! Recognizing the Thought Traps that Negatively Impact How...
See it and Catch it! Recognizing the Thought Traps that Negatively Impact How...
 
ABO Blood grouping in-compatibility in pregnancy
ABO Blood grouping in-compatibility in pregnancyABO Blood grouping in-compatibility in pregnancy
ABO Blood grouping in-compatibility in pregnancy
 
Creeping Stroke - Venous thrombosis presenting with pc-stroke.pptx
Creeping Stroke - Venous thrombosis presenting with pc-stroke.pptxCreeping Stroke - Venous thrombosis presenting with pc-stroke.pptx
Creeping Stroke - Venous thrombosis presenting with pc-stroke.pptx
 
Intro to disinformation and public health
Intro to disinformation and public healthIntro to disinformation and public health
Intro to disinformation and public health
 
Circulatory Shock, types and stages, compensatory mechanisms
Circulatory Shock, types and stages, compensatory mechanismsCirculatory Shock, types and stages, compensatory mechanisms
Circulatory Shock, types and stages, compensatory mechanisms
 
Difference Between Skeletal Smooth and Cardiac Muscles
Difference Between Skeletal Smooth and Cardiac MusclesDifference Between Skeletal Smooth and Cardiac Muscles
Difference Between Skeletal Smooth and Cardiac Muscles
 
Part I - Anticipatory Grief: Experiencing grief before the loss has happened
Part I - Anticipatory Grief: Experiencing grief before the loss has happenedPart I - Anticipatory Grief: Experiencing grief before the loss has happened
Part I - Anticipatory Grief: Experiencing grief before the loss has happened
 
Physicochemical properties (descriptors) in QSAR.pdf
Physicochemical properties (descriptors) in QSAR.pdfPhysicochemical properties (descriptors) in QSAR.pdf
Physicochemical properties (descriptors) in QSAR.pdf
 
Drug development life cycle indepth overview.pptx
Drug development life cycle indepth overview.pptxDrug development life cycle indepth overview.pptx
Drug development life cycle indepth overview.pptx
 
Obat Aborsi Ampuh Usia 1,2,3,4,5,6,7 Bulan 081901222272 Obat Penggugur Kandu...
Obat Aborsi Ampuh Usia 1,2,3,4,5,6,7 Bulan  081901222272 Obat Penggugur Kandu...Obat Aborsi Ampuh Usia 1,2,3,4,5,6,7 Bulan  081901222272 Obat Penggugur Kandu...
Obat Aborsi Ampuh Usia 1,2,3,4,5,6,7 Bulan 081901222272 Obat Penggugur Kandu...
 
The Clean Living Project Episode 23 - Journaling
The Clean Living Project Episode 23 - JournalingThe Clean Living Project Episode 23 - Journaling
The Clean Living Project Episode 23 - Journaling
 
TEST BANK For Porth's Essentials of Pathophysiology, 5th Edition by Tommie L ...
TEST BANK For Porth's Essentials of Pathophysiology, 5th Edition by Tommie L ...TEST BANK For Porth's Essentials of Pathophysiology, 5th Edition by Tommie L ...
TEST BANK For Porth's Essentials of Pathophysiology, 5th Edition by Tommie L ...
 
Top 10 Most Beautiful Chinese Pornstars List 2024
Top 10 Most Beautiful Chinese Pornstars List 2024Top 10 Most Beautiful Chinese Pornstars List 2024
Top 10 Most Beautiful Chinese Pornstars List 2024
 

Glycogen metabolism

  • 2. GLYCOGEN METABOLISM Carl Cori and Gerty -glycogen degradation.  Glycogen synthesis, Luis Leloir (Argentina) was awarded Nobel prize in 1970. Earl Sutherland studied the role of cyclic AMP as the second messenger in glycogenolysis. Glycogen is a homopolysaccharide with glucose units linked in alpha-1, 4 linkages (straight line) and alpha-1, 6 linkages (branching point). Branching makes the molecule more globular and less space-consuming.
  • 3.
  • 4. FIG. Pathways of glycogenesis and glycogenolysis in the liver.
  • 5.
  • 6.
  • 7. FIG. Control of glycogen phosphorylase in muscle. The sequence of reactions arranged as a cascade allows amplification of the hormonal signal at each step. n, number of glucose residue
  • 8.
  • 9.
  • 10. Fig . Coordinated control of glycogenolysis and glycogenesis by cAMP dependent protein kinase.  Coordinated control of glycogenolysis and glycogenesis by cAMP-dependent protein kinase.  The reactions that lead to glycogenolysis as a result of an increase in cAMP concentrations are shown with bold arrows.  Inhibited by activation of protein phosphatase-1 are shown with dashed arrows.  The reverse occurs when cAMP concentrations decrease as a result of phosphodiesterase activity, leading to glycogenesis.
  • 11. Functions of Glycogen 1. storage form , liver and muscle. liver glycogen is to provide glucose during fasting. The glycogen content of liver (10 g/100 g tissue)  skeletal muscle (1–2 g/100 g) 2. liver glycogen is broken down and helps to maintain blood glucose level.  After taking food, blood sugar tends to rise,
  • 12. Functions of Glycogen continue…  After taking food, blood sugar tends to rise, which causes glycogen deposition in liver. About 5 hours after taking food, the blood sugar tends to fall. But, glycogen is lyzed to glucose so that the energy needs are met. After about 18 hours fasting, most of the liver glycogen is depleted, when depot fats are hydrolyzed and energy requirement is met by fatty acid oxidation . 3. The function of muscle glycogen is to act as reserve fuel for muscle contraction. 4. All the enzymes related to glycogen metabolism are cytoplasmic.
  • 13.
  • 15. Step 1 -Glycogen Phosphorylase i. Glycogen phosphorylase removes glucose as glucose- 1- phosphate from glycogen (phosphorolysis) . It contains pyridoxal phosphate (PLP) as a prosthetic group. The alpha-1, 4 linkages in the glycogen are cleaved. ii. It removes glucose units one at a time. Enzyme sequentially hydrolyzes alpha-1, 4 glycosidic linkages,
  • 16.
  • 17. Step 2.Debranching by Bifunctional (Two) Enzymes i. A block of 3 glucose residues (trisaccharide unit) are transferred from the branching point to another branch.  Enzyme is alpha-1, 4 → alpha-1, 4 glucan transferase. ii. Now the branch point is free.  Then alpha-1, 6- glucosidase (debranching enzyme) can hydrolyze the remaining glucose unit held in alpha-1, 6 linkage at the branch point . iii. This glucose residue is released as free glucose ,the ratio of glucose-1-phosphate to free glucose is about 8:1. iv. The transferase and alpha-1, 6-glucosidase will together convert the branch point to a linear one.  With the removal of the branch point, phosphorylase nzyme can proceed with its action.
  • 18.
  • 19. Sep 3. Phosphoglucomutase Phosphorylase reaction produces glucose-1- phosphatem while debranching enzyme releases glucose. The glucose- 1-phosphate is converted to glucose-6- phosphate by phosphoglucomutase .
  • 20. Step 4.Glucose-6-phosphatase in Liver Next, hepatic glucose-6-phosphatase hydrolyzes glucose- 6-phosphate to glucose. The free glucose is released to the bloodstream.
  • 21. Muscle lacks Glucose -6-phosphatase Muscle will not release glucose to the bloodstream, because muscle tissue does not contain the glucose-6-phosphatase. Instead, in muscle, glucose-6-phosphate undergoes glycolysis to produce ATP for muscle contraction.
  • 22. Energetics Glycogenolysis i. The energy yield from one glucose residue derived from glycogen is 3 ATP molecules, because no ATP is required for initial phosphorylation of glucose (step 1 of glycolysis). ii. If glycolysis starts from free glucose only 2 ATPs are produced.
  • 24. GLYCOGEN SYNTHESIS (GLYCOGENESIS) The glycogen synthesis occurs by a pathway distinctly different from the reversal of glycogen breakdown, which would prevent the operation of futile cycles. The steps are:
  • 25. Step-1. Activation of Glucose UDP glucose is formed from glucose-1-phosphate and UTP (uridine triphosphate) by the enzyme UDP- glucose pyrophosphorylase.
  • 26.
  • 27. Step- 2.Glycogen Synthase The glucose moiety from UDP-glucose is transferred to a glycogen primer (glycogenin) molecule. The primer is essential to accept the glycosyl unit. The primer is made up of a protein-carbohydrate complex. It is a dimeric protein, having two identical monomers. An oligosaccharide chain of 7 glucose units is added to each monomer.
  • 28.
  • 29. Step- 2.Glycogen Synthase continue…. In the next step, activated glucose units are sequentially added by the enzyme glycogen synthase . The glucose unit is added to the nonreducing (outer) end of the glycogen primer to form an alpha-1, 4 glycosidic linkage and UDP is liberated.
  • 30.
  • 31. Glycogen Synthase and Primer The glycogen primer is formed by autoglycosylation of glycogenin. Glycogenin is a dimeric protein, the monomers glycosylating each other using UDP glucose till seven glucose units are added.  This molecule acts as the glycogen primer to which glucose units are added by glycogen synthase.
  • 32. Step-3.Branching Enzyme i. The glycogen synthase can add glucose units only in alpha-1, 4 linkage.  A branching enzyme is needed to create the alpha-1, 6 linkages. ii. When the chain is lengthened to 11–12 glucose residues, the branching enzyme will transfer a block of 6 to 8 glucose residues from this chain to another site on the growing molecule. The enzyme amylo- [1, 4]→[1, 6]-transglucosidase (branching enzyme) forms this alpha-1, 6 linkage. iii. To this newly created branch, further glucose units can be added in alpha-1, 4 linkage by glycogen synthase.
  • 33. Regulation of Glycogen Metabolism i. The synthesis and degradation pathways are reciprocally regulated to prevent futile cycles. ii. The phosphorylated form of glycogen phosphorylase is active; but glycogen synthase becomes inactive on phosphorylation.  The covalently modified phosphorylase is active even without AMP.  Active (dephosphorylated) glycogen synthase is responsive to the action of glucose-6- phosphate.  Covalent modification modulates the effect of allosteric regulators.  The hormonal control by covalent modification and allosteric regulation are interrelated. iii. These hormones act through a second messenger, cyclic AMP (cAMP) iv. The covalent modification of glycogen phosphorylase and synthase is by a cyclic AMP mediated
  • 34. Regulation of Glycogen Metabolism iv. The covalent modification of glycogen phosphorylase and synthase is by a cyclic AMP mediated cascade.  Specific protein kinases bring about phosphorylation and protein phosphatases cause dephosphorylation.
  • 35. Regulation of Glycogen Metabolism Generation of Cyclic AMP (cAMP) Protein Kinase Activation Phosphorylase Kinase Activation Glycogen Phosphorylase in Liver and Muscle Glycogen Synthase
  • 36.
  • 37.
  • 38.
  • 39. Generation of Cyclic AMP (cAMP) i. Both liver and muscle phosphorylases are activated by a cyclic AMP mediated activation cascade triggered by the hormonal signal. ii. The hormones epinephrine and glucagon can activate liver glycogen phosphorylase but glucagon has no effect on the muscle. iii. When the hormone binds to a specific receptor on the plasma membrane, the enzyme adenyl cyclase is activated which converts ATP to cyclic AMP (cAMP). iv. When level of cyclic AMP rises, it will activate a protein kinase .
  • 40. Protein Kinase Activation The protein kinase is inactive when the catalytic (C) and regulatory (R) subunits are associated with each other. Earl Sutherland studied the role of cyclic AMP as the second messenger in glycogenolysis. The cAMP combines with the R subunit so that the C subunit is free to have its catalytic activity.  PKA is an enzyme that can phosphorylate serine and threonine residues of several enzyme proteins and is activated by cAMP which combines with the regulatory subunit of PKA. In the absence of cAMP, PKA is an inactive tetramer.
  • 42. Protein Kinase Activation The intracellular concentration of cAMP therefore decides the level of active PKA.  cAMP level depends on the activity of adenylate cyclase and phosphodiesterase. Cyclic AMP level is increased by glucagon and decreased by insulin.
  • 43.
  • 44. Phosphorylase Kinase Activation  The active protein kinase can now convert the phosphorylase  kinase to an active phosphorylated form, which converts  phosphorylase-b to phosphorylase-a .  Phosphorylase kinase itself is a tetrameric enzyme (alpha, beta, gamma, delta).  The gamma subunit has the catalytic site and the other 3 subunits have regulatory effects.  Phosphorylase kinase is activated by Ca++ and phosphorylation of alpha and beta subunits by PKA.  Phosphorylation of alpha and beta subunits relieves autoinhibition of catalytic activity of gamma subunit.  Binding of Ca++ to the delta subunit which is identical to calmodulin (CaM) is also necessary for full activity of delta subunit. since it also has a role in dysregulating the
  • 45. Phosphorylase Kinase Activation continue..  It also has a role in dysregulating the gamma subunit.  Calcium triggers muscle contraction as well as glycogen breakdown through the action of phosphorylase kinase.  The rate of glycogenolysis is linked to rate of muscle contraction.
  • 46.
  • 47. Phosphorylase Kinase Activation continue..  The dephosphorylation of the active form by protein phosphatase 1 (PP1) involves removal of phosphate group from phosphorylase a and alpha and beta subunits of phosphorylase kinase.  The activity of PP1 is controlled differently in liver and muscle.  The catalytic subunit of PP1 in muscle is active only when it is bound to glycogen through the glycogen binding GM subunit.  The phosphorylation of PP1 by an insulin stimulated protein kinase (site1) activates the enzyme where as phosphorylation at site 2 by PKA makes its action ineffective.  When cAMP level is high, PP1 is inhibited by inhibitor1 which is activated by phosphorylation by PKA.  The effect of cyclic AMP is not only by increasing the phosphorylation of enzymes, but also by decreasing dephosphorylation.
  • 48. Glycogen Phosphorylase in Liver a. Liver: The liver phosphorylase-b is the inactive form.  It becomes active on phosphorylation.  The active enzyme is denoted as phosphorylase-a.  The enzyme is inhibited by ATP and glucose-6-phosphate.  In the liver the PP1 is regulated differently through the intermediary of glycogen binding subunit (GL).  GL complex can bind to R and T forms of phosphorylase a.  The phosphate group attached to ser14 is exposed only in the T state, so that PP1 can convert phosphorylase a to phosphorylase b.  Glucose is an allosteric inhibitor of phosphorylase a.  Insulin favors this effect by promoting the uptake and phosphorylation of glucose.
  • 49. Glycogen Phosphorylase in Muscle b. Muscle: Skeletal muscle glycogen is degraded only when the demand for ATP is high.  The regulation of glycogenolysis in skeletal muscle is by epinephrine.  Glucagon has no effect on muscle glycogenolysis.  AMP formed by degradation of ATP during muscle contraction is an allosteric activator of phosphorylase b.  The active form of phosphorylase is referred to as ‘a’ (active, phosphorylated) and the relatively inactive dephosphorylated form as ‘b’.  The active glycogen synthase (a) is dephosphorylated and phosphorylated (b) is relatively inactive.  Glycogen phosphorylase is activated by phosphorylation by phosphorylase kinase that adds phosphate group to a specific serine residue of phosphorylase b (ser14).  This phosphorylase kinase, in
  • 50. FIG. Control of glycogen phosphorylase in muscle. The sequence of reactions arranged as a cascade allows amplification of the hormonal signal at each step. n, number of glucose residue
  • 51. Glycogen Phosphorylase in Muscle  This phosphorylase kinase, in turn, is activated by protein kinase A or cyclic AMP dependent protein kinase.  Phosphoprotein phosphatase I dephosphorylates both phosphorylase kinase and phosphorylase b. Phosphorylase b is sensitive to allosteric effectors like AMP but phosphorylase a is not sensitive. High concentration of ATP and glucose-6-phosphate in the cell will inhibit phosphorylase b.
  • 52. Glycogen Synthase i. Glycogen synthase and phosphorylase activities are reciprocally regulated . ii. The same protein kinase, which phosphorylates the phosphorylase kinase would also phosphorylate glycogen synthase. iii. The activity of the glycogen synthase is markedly decreased on phosphorylation.  Insulin promotes glycogen synthesis by favouring dephosphorylation.  Glycogen synthase is active in the dephosphorylated state.  Phosphorylase kinase can phosphorylate glycogen synthase and inactivate the enzyme.  PKA can also inactivate the enzyme by phosphorylation.  Ca++ and calcium dependent cam kinase also phosphorylate the enzyme.
  • 53.
  • 54.
  • 55. Glycogen Synthase continue…. Relative rates of glycogen synthesis and breakdown are controlled by the action of PKA, phosphorylase kinase and PP1. PP1 can activate glycogen synthase only after dephosphorylating and inactivating phosphorylase a. The regulation of glycogen phosphorylase and synthase is a typical example of multisite phosphorylation (primary and secondary sites) for metabolic regulation. Control by allosteric effectors is superimposed on covalent modification.  Glucose-6-phosphate can activate glycogen synthesis. Insulin activates PP1 and PDE which decreases cAMP level and increases G6P level to promote glycogen synthesis.
  • 56. Glycogen Synthase continue…. The reciprocal regulation of glycogenolysis and glycogenesis is by covalent modification (phosphorylation and dephosphorylation).  Insulin and glucagon are the major regulatory hormones, although epinephrine has stimulatory effect on glycogenolysis in both liver and muscle. They bring about alterations in the activity of protein kinases and phosphatases by varying the level of cAMP.
  • 57. Summary of Glycogen Regulation i. The key enzyme for glycogenolysis is phosphorylase, which is activated by glucagon and epinephrine, under the stimulus of hypoglycemia. ii. The key enzyme for glycogen synthesis is glycogen synthase, the activity of which is decreased by glucagon and epinephrine but is enhanced by insulin, under the stimulus of hyperglycemia .  Glycogen metabolism is regulated by coordinated regulation of glycogen synthase and glycogenphosphorylase.  The regulatory mechanisms include:  Allosteric control as well as hormonal control by covalent modification of enzymes.  The allosteric effectors are ATP, glucose-6-phosphate and AMP.
  • 58.
  • 59.
  • 60.
  • 61. GLYCOGEN STORAGE DISEASES • These are inborn-errors of metabolism.
  • 62.
  • 63.
  • 64. Glycogen Storage Disease Type-I 1. It is also called Von Gierke’s Disease.  Most common type of glycogen storage disease is type I. 2. Incidence is 1 in 100,000 live births. 3. Glucose-6-phosphatase is deficient. 4. Fasting hypoglycemia that does not respond to stimulation by adrenaline.  The glucose cannot be released from liver during over night fasting 5. Hyperlipidemia, lactic acidosis and ketosis. 6. Glucose-6-phosphate is accumulated, so it is channeled to HMP shunt pathway producing more ribose and more purine nucleotides. 7. Purines are then catabolized to uric acid, leading to hyperuricemia. 8. Glycogen gets deposited in liver.  Massive liver enlargement may lead to cirrhosis. 9. Children usually die in early childhood. 10. Treatment is to give small quantity of food at frequent intervals.  Other types : 1 in 1 million births
  • 65. Pompe’s disease • infantile-onset Pompe’s disease Myozyme (recombinant human acid alpha glucosidase, rhGAA) is administered intravenously.